Cabaletta Bio (CABA) Other Accumulated Expenses (2018 - 2025)
Cabaletta Bio's (CABA) quarterly Other Accumulated Expenses came in at $80000.0 in Q4 2025, up 100.0% year-on-year from $40000.0 in Q4 2024, and up 166.67% quarter-over-quarter from $30000.0 in Q3 2025.
Cabaletta Bio (CABA) Other Accumulated Expenses (2018 - 2025) Analysis & Trends
Cabaletta Bio's Other Accumulated Expenses history runs 8 years deep, the most recent figure standing at $80000.0 for Q4 2025.
- On a quarterly basis, Other Accumulated Expenses rose 100.0% year-over-year to $80000.0 in Q4 2025; TTM through Dec 2025 was $80000.0, a 100.0% increase from a year earlier, with the FY2025 full-year figure at $80000.0, up 100.0% from the prior year.
- Other Accumulated Expenses climbed to $80000.0 in Q4 2025 per CABA's latest filing, from $30000.0 in the prior quarter.
- Across five years, Other Accumulated Expenses topped out at $83000.0 in Q1 2021 and bottomed at $16000.0 in Q2 2025.
- The 5-year median for Other Accumulated Expenses is $43500.0 (2021), against an average of $44150.0.
- Across the five-year window, Other Accumulated Expenses slumped 62.86% in 2021 and jumped 100.0% in 2025, its largest moves.
- Year by year, Other Accumulated Expenses stood at $54000.0 in 2021, then slipped by 27.78% to $39000.0 in 2022, then grew by 2.56% to $40000.0 in 2023, then changed by 0.0% to $40000.0 in 2024, then soared by 100.0% to $80000.0 in 2025.
- Per Business Quant, the three latest CABA Other Accumulated Expenses figures stand at $80000.0 (Q4 2025), $30000.0 (Q3 2025), and $16000.0 (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Cabaletta Bio | 182.04 Mn | 182.04 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 80,000.00 |
| Sep 30, 2025 | 30,000.00 |
| Jun 30, 2025 | 16,000.00 |
| Mar 31, 2025 | 50,000.00 |
| Dec 31, 2024 | 40,000.00 |
| Sep 30, 2024 | 30,000.00 |
| Jun 30, 2024 | 20,000.00 |
| Mar 31, 2024 | 50,000.00 |
| Dec 31, 2023 | 40,000.00 |
| Sep 30, 2023 | 30,000.00 |
| Jun 30, 2023 | 20,000.00 |
| Mar 31, 2023 | 50,000.00 |
| Dec 31, 2022 | 39,000.00 |
| Sep 30, 2022 | 71,000.00 |
| Jun 30, 2022 | 23,000.00 |
| Mar 31, 2022 | 58,000.00 |
| Dec 31, 2021 | 54,000.00 |
| Sep 30, 2021 | 52,000.00 |
| Jun 30, 2021 | 47,000.00 |
| Mar 31, 2021 | 83,000.00 |